Literature DB >> 31599462

Symptoms among emerging adults with inflammatory bowel disease: a descriptive study.

Kendra Kamp1, Sharon Dudley-Brown2, Margaret Heitkemper3, Gwen Wyatt4, Barbara Given4.   

Abstract

Individuals with inflammatory bowel disease (IBD) are commonly diagnosed when they are between the ages of 18-29, a developmental period known as emerging adulthood. Typically, emerging adults are subsumed into the category of adults even though emerging adults have unique developmental needs. In this descriptive study of IBD in emerging adults, the aims were to (a) determine the prevalence of symptoms; (b) describe the severity of symptoms and their interference with daily activities; and (c) examine the association between individual symptom severity and presence of fatigue. Emerging adults with IBD were recruited using web-based convenience sampling. Sixty-one individuals met the inclusion criteria. They had a mean age of 24.7 and a disease duration of 6.4 years. The most prevalent symptoms reported were: fatigue (n = 44, 72.1%), abdominal cramps (n = 39, 63.9%), abdominal pain (n = 39, 63.9%), and diarrhea (n = 38, 62.3%). The symptom with the greatest severity and interference with daily activities was fatigue. Abdominal cramps, abdominal pain, diarrhea, passing gas, and abdominal tenderness were associated with fatigue when controlling for age, emerging adulthood, gender, time since diagnosis, and current steroid use. Among emerging adults with IBD, fatigue is the most prevalent symptom and is the symptom with the greatest severity and interference with daily activities. These results suggest a need for interventions aimed at reducing both fatigue and gastrointestinal symptoms among emerging adults with IBD.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Crohn's disease; inflammatory bowel disease; symptoms; ulcerative colitis; young adult

Mesh:

Year:  2019        PMID: 31599462      PMCID: PMC6954301          DOI: 10.1002/nur.21985

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  38 in total

1.  Emerging adulthood. A theory of development from the late teens through the twenties.

Authors:  J J Arnett
Journal:  Am Psychol       Date:  2000-05

2.  Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients.

Authors:  Denise Herzog; Nicolas Fournier; Patrick Buehr; Vanessa Rueger; Rebekka Koller; Klaas Heyland; Andreas Nydegger; Christian P Braegger
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-08       Impact factor: 2.566

3.  Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap.

Authors:  Afrin Kamal; Ruthvik Padival; Bret Lashner
Journal:  Inflamm Bowel Dis       Date:  2018-11-29       Impact factor: 5.325

4.  Symptom clusters in adults with inflammatory bowel disease.

Authors:  Samantha Conley; Deborah D Proctor; Sangchoon Jeon; Robert S Sandler; Nancy S Redeker
Journal:  Res Nurs Health       Date:  2017-08-17       Impact factor: 2.228

5.  Common symptoms and stressors among individuals with inflammatory bowel diseases.

Authors:  Sunny Singh; Andrea Blanchard; John R Walker; Lesley A Graff; Norine Miller; Charles N Bernstein
Journal:  Clin Gastroenterol Hepatol       Date:  2011-05-20       Impact factor: 11.382

6.  Fatigue management in patients with IBD: a randomised controlled trial.

Authors:  Lauran Vogelaar; Adriaan van't Spijker; Reinier Timman; Antonie J P van Tilburg; DirkJan Bac; Ton Vogelaar; Ernst J Kuipers; Jan J V van Busschbach; Christien J van der Woude
Journal:  Gut       Date:  2013-07-24       Impact factor: 23.059

7.  Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).

Authors:  Waguih W IsHak; Dana Pan; Alexander J Steiner; Edward Feldman; Amy Mann; James Mirocha; Itai Danovitch; Gil Y Melmed
Journal:  Inflamm Bowel Dis       Date:  2017-05       Impact factor: 5.325

8.  Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

Authors:  Edward V Loftus; Brian G Feagan; Jean-Frédéric Colombel; David T Rubin; Eric Q Wu; Andrew P Yu; Paul F Pollack; Jingdong Chao; Parvez Mulani
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

Review 9.  Review article: Description and management of fatigue in inflammatory bowel disease.

Authors:  W Czuber-Dochan; E Ream; C Norton
Journal:  Aliment Pharmacol Ther       Date:  2013-01-13       Impact factor: 8.171

10.  A stress management programme for Crohn's disease.

Authors:  E García-Vega; C Fernandez-Rodriguez
Journal:  Behav Res Ther       Date:  2004-04
View more
  3 in total

1.  Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease.

Authors:  Kendra J Kamp; Kindra Clark-Snustad; Mitra Barahimi; Scott Lee
Journal:  Gastroenterol Nurs       Date:  2022 Jan-Feb 01       Impact factor: 0.978

2.  Earnings during adulthood in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study.

Authors:  Petter Malmborg; Åsa H Everhov; Jonas Söderling; Jonas F Ludvigsson; Gustaf Bruze; Ola Olén
Journal:  Aliment Pharmacol Ther       Date:  2022-08-02       Impact factor: 9.524

3.  Dietary patterns, beliefs and behaviours among individuals with inflammatory bowel disease: a cross-sectional study.

Authors:  K J Kamp; B Pennings; D Javelli; G Wyatt; B Given
Journal:  J Hum Nutr Diet       Date:  2020-06-14       Impact factor: 3.089

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.